Related Experiment Videos
Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant
Insights
Lithium use during pregnancy can lead to severe heart defects in newborns, including tricuspid regurgitation and atrial flutter. This case highlights the risks of lithium carbonate exposure in the first trimester, impacting infant cardiac health.
Area of Science:
- Cardiology
- Neonatology
- Teratology
Background:
- Congenital heart defects are a significant concern in neonatal care.
- Prenatal exposure to certain medications can increase the risk of birth defects.
- Lithium carbonate is a medication used to treat bipolar disorder.
Observation:
- A newborn presented with massive tricuspid regurgitation, atrial flutter, congestive heart failure, and elevated serum lithium levels.
- This case represents the first documented instance of initial presentation with both tricuspid regurgitation and atrial flutter in an infant exposed to lithium.
- The patient is the 11th described infant with cardiac disease following first-trimester lithium compound exposure.
Findings:
- Sixty-three percent of infants exposed to lithium compounds in the first trimester exhibit tricuspid valve involvement.
- Lithium carbonate exposure during early pregnancy is associated with an increased incidence of congenital heart disease.
- Prenatal lithium consumption can result in neonatal complications such as neurologic depression, cyanosis, and cardiac arrhythmia.
Implications:
- Lithium carbonate should be used with extreme caution during the first trimester of pregnancy due to potential cardiac teratogenicity.
- Increased awareness and monitoring are crucial for infants exposed to lithium in utero.
- Further research is warranted to elucidate the precise mechanisms of lithium-induced congenital heart defects.
Abstract:
A newborn with massive tricuspid regurgitation, atrial flutter, congestive heart failure, and a high serum lithium level is described. This is the first patient to initially manifest tricuspid regurgitation and atrial flutter, and the 11th described patient with cardiac disease among infants exposed to lithium compounds in the first trimester of pregnancy. Sixty-three percent of these infants had tricuspid valve involvement. Lithium carbonate may be a factor in the increasing incidence of congenital heart disease when taken during early pregnancy. It also causes neurologic depression, cyanosis, and cardiac arrhythmia when consumed prior to delivery.